Related Experiment Video
Updated: Feb 2, 2026

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure
Published on: November 29, 2018
Comprehensive plasma and tissue profiling reveals systemic metabolic alterations in cardiac hypertrophy and failure
Oliver J Müller1,2, Markus B Heckmann1,2, Lin Ding1,2
1Internal Medicine III, University Hospital Heidelberg, Im Neuenheimer Feld 410, Heidelberg, Germany.
Aims:
Heart failure is characterized by structural and metabolic cardiac remodelling. The aim of the present study is to expand our understanding of the complex metabolic alterations in the transition from pathological hypertrophy to heart failure and exploit the results from a translational perspective.
Methods And Results:
Mice were subjected to transverse aortic constriction (TAC) or sham surgery and sacrificed 2 weeks, 4 weeks, or 6 weeks after the procedure. Samples from plasma, liver, skeletal muscle, and heart were collected and analysed using metabolomics. Cardiac samples were also analysed by transcriptional profiling. Progressive alterations of key cardiac metabolic pathways and gene expression patterns indicated impaired mitochondrial function and a metabolic switch during transition to heart failure. Similar to the heart, liver, and skeletal muscle revealed significant metabolic alterations such as depletion of essential fatty acids and glycerolipids in late stages of heart failure. Circulating metabolites, particularly fatty acids, reflected cardiac metabolic defects, and deteriorating heart function. For example, inverse correlation was found between plasma and the heart levels of triacylglycerol (C18:1, C18:2, C18:3), and sphingomyelin (d18:1, C23:0) already at an early stage of heart failure. Interestingly, combining metabolic and transcriptional data from cardiac tissue revealed that decreased carnitine shuttling and transportation preceded mitochondrial dysfunction. We, thus, studied the therapeutic potential of OCTN2 (Organic Cation/Carnitine Transporter 2), an important factor for carnitine transportation. Cardiac overexpression of OCTN2 using an adeno-associated viral vector significantly improved ejection fraction and reduced interstitial fibrosis in mice subjected to TAC.
Conclusion:
Comprehensive plasma and tissue profiling reveals systemic metabolic alterations in heart failure, which can be used for identification of novel biomarkers and potential therapeutic targets.
Insights
Heart failure involves significant metabolic changes in the heart and body. Targeting carnitine transport via OCTN2 shows promise for treating heart failure.
Area of Science:
- Cardiovascular Biology
- Metabolomics
- Molecular Cardiology
Background:
- Heart failure is marked by structural and metabolic cardiac remodeling.
- Understanding metabolic shifts during heart failure progression is crucial for therapeutic development.
Purpose of the Study:
- To investigate complex metabolic alterations during the transition from pathological hypertrophy to heart failure.
- To identify novel biomarkers and therapeutic targets from systemic metabolic profiling.
Main Methods:
- Mice underwent transverse aortic constriction (TAC) or sham surgery.
- Metabolomic and transcriptional profiling of plasma, liver, skeletal muscle, and heart tissues were performed at 2, 4, and 6 weeks post-surgery.
- Cardiac overexpression of Organic Cation/Carnitine Transporter 2 (OCTN2) was investigated as a therapeutic strategy.
Main Results:
- Progressive alterations in cardiac metabolic pathways and gene expression indicated impaired mitochondrial function and a metabolic switch.
- Significant metabolic changes, including depletion of essential fatty acids, were observed in the liver and skeletal muscle.
- Circulating metabolites, particularly fatty acids, correlated with cardiac defects and heart function decline.
- Decreased carnitine shuttling preceded mitochondrial dysfunction, highlighting OCTN2's role.
- Cardiac OCTN2 overexpression improved ejection fraction and reduced fibrosis in TAC mice.
Conclusions:
- Systemic metabolic profiling reveals widespread alterations in heart failure.
- Metabolic and transcriptional data identify novel biomarkers and potential therapeutic targets for heart failure.
- Targeting carnitine transport through OCTN2 offers a promising therapeutic avenue for heart failure.
Related Concept Videos
What is Metabolism?
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Second Order systems II
Pathophysiology of Heart Failure

